Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 18, 2005

View Archived Issues

Antiinflammatory properties of drugs acting on the renin-angiotensin system

New data on the survival benefits of Provenge in advanced prostate cancer

Low-dose doxepin therapy shows promise in primary sleep maintenance insomnia

MAZ-51 directly inhibits tumor growth in preclinical models

Discovery of a novel family of antimicrobial peptides

Update on the safety and antiviral effects of Actilon in hepatitis C

Phase I study of ADMVA HIV vaccine opens enrollment

BAL-8557 enters phase II for esophageal candidiasis

Abgenix to receive milestone payment from Chiron for oncology antibody

BioLineRx inlicenses three new preclinical compounds

deCODE submits IND for novel antiatherosclerosis compound DG-041

Roche's AmpliChip CYP450 Test receives FDA clearance

Positive results from field efficacy study of FluINsure

Phase III study of ferumoxytol as intravenous iron replacement therapy

Phase IIa trials of PT-141 in FSD and ED complete enrollment

Series A financing at Chelsea Therapeutics

BAY-43-9006 studied for pancreatic cancer in NCI-sponsored phase II study

Good safety profile found for GR-270773 in septic patients

Clinical trial confirms the benefits of conivaptan in the management of hyponatremia

Phase II data on the efficacy of PHP in distributive shock

First clinical data on the efficacy of peginterferon alfa-2b monotherapy in chronic hepatitis B

New data on ethacrynic acid

Corgentech files IND to begin phase I/II trial of NF-kappaB Decoy in eczema

Combinations of modafinil and an antidepressant agent claimed by Cephalon

Pfizer claims PDE5 inhibitors for use in hypertension and diabetes

AstraZeneca scientists describe new agents for the treatment of pain

Researchers at ACRAF present novel analgesic compounds

Agents for the treatment of proliferative disorders described in patent literature

New therapeutic candidates for the treatment of Alzheimer's disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...